# AmlaMax (Emblica officinalis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/amlamax
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Emblica officinalis, Indian gooseberry, Amla, Amalaki, Phyllanthus emblica, Emblic myrobalan, Myrobalan, Dhatriphala, Amalaka, Aonla

## Overview

AmlaMax is a standardized extract of Emblica officinalis (Indian gooseberry) concentrated in low-molecular-weight polyphenols, including emblicanin A and B, punigluconin, and pedunculagin. These tannoid compounds act as potent [free radical scaveng](/ingredients/condition/antioxidant)ers and modulate [inflammatory](/ingredients/condition/inflammation) signaling cascades, forming the basis of its proposed [cardiovascular](/ingredients/condition/heart-health) and [hepatoprotective](/ingredients/condition/detox) effects.

## Health Benefits

• [Antioxidant](/ingredients/condition/antioxidant) properties through polyphenolic compounds (traditional use evidence only)
• Potential [anti-inflammatory](/ingredients/condition/inflammation) effects (preclinical data, human studies needed)
• Possible [cardiovascular](/ingredients/condition/heart-health) support for hypertension (ethnomedical evidence, no RCTs)
• [Hepatoprotective](/ingredients/condition/detox) activity suggested (traditional use, clinical validation lacking)
• May support metabolic health (mechanism studies only, no human trials)

## Mechanism of Action

AmlaMax's primary bioactives—emblicanin A, emblicanin B, and pedunculagin—scavenge [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) and chelate transition metals, reducing lipid peroxidation measured via TBARS assays. These polyphenols inhibit NF-κB nuclear translocation, suppressing downstream [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-1β, and IL-6. Additionally, preclinical data suggest inhibition of ACE (angiotensin-converting enzyme) activity and upregulation of endothelial nitric oxide synthase (eNOS), which may contribute to vasodilatory and antihypertensive effects.

## Clinical Summary

Most evidence for AmlaMax derives from in vitro and animal studies, with limited but emerging human clinical data. One small open-label pilot trial (n=15) examining a related standardized amla extract reported reductions in LDL oxidation and improvements in total [antioxidant](/ingredients/condition/antioxidant) capacity after 12 weeks, though the absence of a placebo arm limits interpretation. A separate preliminary human study observed modest reductions in systolic [blood pressure](/ingredients/condition/heart-health) (~6 mmHg) and CRP levels over 8 weeks at 500 mg/day, but sample sizes were insufficient for statistical power. Randomized, double-blind, placebo-controlled trials with AmlaMax specifically are lacking, meaning current cardiovascular claims rest primarily on ethnomedical tradition and preclinical mechanistic data.

## Nutritional Profile

AmlaMax is a standardized extract of Emblica officinalis (Indian Gooseberry) concentrated primarily for its polyphenolic content. Key bioactive compounds include low molecular weight hydrolyzable tannins: emblicanin A (approx. 35-40% of total polyphenols in standardized extract) and emblicanin B (approx. 25-30%), which are unique to this species and considered more stable and bioavailable than ascorbic acid-bound vitamin C found in raw amla fruit. Punigluconin and pedunculagin are present as additional ellagitannins. The extract typically delivers a standardized total polyphenol content of 45-60% by dry weight (as per commercial AmlaMax specifications). Raw amla fruit context: fresh fruit contains approximately 600-900 mg/100g of vitamin C equivalents, though in AmlaMax the vitamin C activity is largely attributed to tannin-bound forms rather than free ascorbic acid, offering superior stability during processing and storage. Gallic acid content is approximately 1.2-2.0% in the standardized extract. Chebulinic acid and chebulagic acid are present at minor concentrations (<1%). Rutin and quercetin glycosides contribute flavonoid fractions at approximately 0.5-1.5% combined. Mineral content in the extract is minimal due to concentration processing but raw fruit provides calcium (~25 mg/100g), phosphorus (~27 mg/100g), and iron (~0.5 mg/100g). Fiber content is negligible in extract form. Protein is <2% in extract. Bioavailability note: emblicanins undergo hydrolysis in the gut releasing ellagic acid and gallic acid; ellagic acid is further metabolized by gut microbiota into urolithins (urolithin A and B), which are the primary systemically absorbed metabolites — bioavailability is therefore [microbiome](/ingredients/condition/gut-health)-dependent and interindividual variability is significant. The tannin-complexed vitamin C form demonstrates greater thermal and oxidative stability compared to free ascorbic acid, with studies suggesting retention of [antioxidant activity](/ingredients/condition/antioxidant) after processing conditions that would degrade free ascorbic acid by >80%.

## Dosage & Preparation

No clinically studied dosage ranges are specified for AmlaMax in any form (extract, powder, or standardized) in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

AmlaMax is generally well tolerated in short-term use at doses up to 1,000 mg/day, with mild gastrointestinal discomfort being the most commonly reported side effect in preliminary studies. Due to demonstrated platelet aggregation inhibition in preclinical models, concurrent use with anticoagulant or antiplatelet medications—including warfarin, aspirin, and clopidogrel—warrants caution and professional oversight. Its ACE-inhibitory activity raises a theoretical additive hypotensive risk when combined with antihypertensive drugs such as lisinopril or amlodipine. Safety data in pregnant or breastfeeding individuals are insufficient to establish a risk profile, and use should be avoided in these populations without medical guidance.

## Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses for AmlaMax itself, with no PubMed PMIDs provided for branded studies. General Emblica officinalis reviews note potential efficacy based on ethnomedical and preclinical data, but emphasize the need for more systematic human research.

## Historical & Cultural Context

Emblica officinalis (Amla) has been used for centuries in Ayurveda and tribal medicine systems to treat diarrhea, jaundice, and [inflammation](/ingredients/condition/inflammation). Historical applications span millennia, positioning it as a key herb in traditional medicine for its nutrient profile and pharmacological potential.

## Synergistic Combinations

Vitamin C, Turmeric, Green Tea Extract, Quercetin, Resveratrol

## Frequently Asked Questions

### What is AmlaMax and how does it differ from regular amla powder?

AmlaMax is a patented, standardized extract of Emblica officinalis fruit calibrated to retain specific low-molecular-weight tannoid polyphenols—emblicanin A and B—that are often degraded during conventional drying of whole amla powder. Regular amla powder contains highly variable polyphenol concentrations depending on harvest, processing, and storage conditions, whereas AmlaMax ensures consistent bioactive delivery per dose, making it more suitable for clinical and supplement applications.

### What is the recommended dosage of AmlaMax for cardiovascular support?

Preliminary human studies have used doses ranging from 500 mg to 1,000 mg per day of standardized Emblica officinalis extract for cardiovascular endpoints, typically divided into one or two daily doses. No official recommended dietary allowance (RDA) or clinically established therapeutic dose exists specifically for AmlaMax, as large-scale RCTs are lacking. Users should follow manufacturer labeling and consult a healthcare provider, particularly when using it alongside antihypertensive or blood-thinning medications.

### Does AmlaMax lower blood pressure?

Preclinical data show that polyphenols in Emblica officinalis inhibit angiotensin-converting enzyme (ACE) activity and enhance nitric oxide bioavailability via eNOS upregulation, both of which can promote vasodilation and reduce blood pressure. A small preliminary human study reported a mean systolic blood pressure reduction of approximately 6 mmHg over 8 weeks at 500 mg/day, but this lacked a control group. The current evidence is insufficient to classify AmlaMax as a clinically proven antihypertensive, and it should not replace prescribed medications.

### Can AmlaMax interact with blood thinners or heart medications?

Yes, there are meaningful interaction risks to consider. AmlaMax's polyphenols have demonstrated antiplatelet activity in preclinical models, creating an additive bleeding risk when combined with anticoagulants like warfarin or antiplatelets like clopidogrel—this combination should only be used under physician supervision with INR monitoring if applicable. Its ACE-inhibitory properties also pose a theoretical synergistic hypotensive effect when taken alongside ACE inhibitor drugs (e.g., lisinopril) or calcium channel blockers (e.g., amlodipine), potentially causing excessive blood pressure drops.

### Is AmlaMax safe for long-term use?

Long-term safety data for AmlaMax specifically are limited, with most tolerability information coming from short-term studies of 8–12 weeks duration. Emblica officinalis has a long history of use in Ayurvedic medicine at food-equivalent doses, which provides some ethnopharmacological reassurance, but high-dose concentrated extract use over months or years has not been rigorously evaluated in controlled human trials. Individuals with liver disease, bleeding disorders, or those on chronic cardiovascular medications should seek medical evaluation before initiating prolonged supplementation.

### What is the bioavailability of AmlaMax compared to whole amla fruit or standard amla powder?

AmlaMax is a branded standardized extract designed to provide concentrated levels of vitamin C and polyphenols in a form intended for better absorption than whole fruit. However, direct bioavailability studies comparing AmlaMax to other amla preparations are limited in published literature. The standardization process may enhance consistency of active compounds, though individual absorption can vary based on digestive factors and formulation additives.

### Is AmlaMax safe to use during pregnancy and breastfeeding?

Adequate safety data specifically for AmlaMax during pregnancy and breastfeeding is not available from clinical trials. While amla (Emblica officinalis) has been traditionally used in Ayurvedic medicine for pregnant women, branded extracts like AmlaMax should only be used during these periods under qualified healthcare provider guidance. Pregnant and nursing individuals should consult their doctor before starting any new supplement.

### How does the evidence quality for AmlaMax's health benefits compare to other amla supplements?

Evidence for AmlaMax specifically is limited to traditional use claims and manufacturer-sponsored research; independent randomized controlled trials on this branded ingredient are lacking. Most clinical research on amla's cardiovascular and antioxidant effects comes from studies on whole fruit or non-branded extracts rather than AmlaMax formulations. Until rigorous independent studies are conducted, claims about AmlaMax should be viewed as preliminary and based primarily on traditional use rather than strong scientific evidence.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*